ULBI

Ultralife Corp

Add to Watchlist

Advanced Chart

6.800

+0.21(3.187%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

6.890

Open

6.690

VWAP

6.71

Vol

50.87K

Mkt Cap

114.67M

Low

6.470

Amount

341.18K

EV/EBITDA(TTM)

10.25

Total Shares

16.62M

149.89M

EV/OCF(TTM)

8.77

P/S(TTM)

0.62

Ultralife Corporation offers products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government, defense and commercial sectors. Its segments include Battery & Energy Products and Communications Systems. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, thin cell and other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems and accessories. The Communications Systems segment includes RF amplifiers, power supplies, cable and connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, integrated communication systems for fixed or vehicle applications and communications and electronics systems design. Its brands include Ultralife, Ultralife HiRate, Lithium Power, McDowell Research, AMTI, ABLE, ACCUTRONICS, ACCUPRO, ENTELLION, SWE Southwest Electronic Energy Group, SWE SEASAFE, among others.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

52.40M

+3.26%

0.160

+23.08%

57.00M

+29.98%

0.270

+2600%

53.00M

+48.48%

0.220

+2100%

Estimates Revision

The market is revising No Change the revenue expectations for Ultralife Corporation (ULBI) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 28.54%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Up

+28.54%

In Past 3 Month

1 Analyst Rating

105.88% Upside

Wall Street analysts forecast ULBI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ULBI is 14.00 USD with a low forecast of 14.00 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

105.88% Upside

Current: 6.800

Low

14.00

Averages

14.00

High

14.00

105.88% Upside

Current: 6.800

Low

14.00

Averages

14.00

High

14.00

Benchmark

Josh Sullivan

Strong Buy

Reiterates

$14

2024-11-15

Reason

Benchmark

Josh Sullivan

Price Target

$14

2024-11-15

Reiterates

Strong Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Ultralife Corp (ULBI.O) is 7.66, compared to its 5-year average forward P/E of 24.63. For a more detailed relative valuation and DCF analysis to assess Ultralife Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

24.63

Current PE

7.66

Overvalued PE

73.32

Undervalued PE

-24.06

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

10.07

Current EV/EBITDA

6.35

Overvalued EV/EBITDA

15.98

Undervalued EV/EBITDA

4.17

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

0.71

Current PS

0.50

Overvalued PS

1.04

Undervalued PS

0.39